Caris Life Sciences and ConcertAI Expand Partnership to Create First-in-Class, Prospectively Matched Clinico-Genomic Research Platform

/PRNewswire/ -- Caris Life Sciences®(Caris), the leading molecular science, artificial intelligence (AI) and machine learning technology company actively...

Related Keywords

Texas ,United States ,New York ,Japan ,Tokyo ,Phoenix ,Arizona ,Cambridge ,Cambridgeshire ,United Kingdom ,Switzerland ,Brian Lamon ,Caris Folfirstai ,Lisa Burgner ,Caris Gpsai ,Megan Duero ,Jeff Elton ,David Spetzler ,Caris Life Sciences Media Contact ,Precision Oncology Research ,Caris Life Sciences Business Development Contact ,Caris Life Sciences ,Caris ,Linkedin ,Concertai Business Development Contact ,Head Of Biopharma Business Development ,Prnewswire Caris Life Sciences ,Unprecedented Scale ,Reference Standard Clinical Data Creates ,Novel Platform ,Chief Executive Officer ,Multi Modal Data ,Whole Exome Sequencing ,Whole Transcriptome Sequencing ,Life Sciences ,Whole Exome ,Caris Assure ,Real World Evidence ,Life Sciences Media Contact ,Life Sciences Business Development Contact ,Business Officer ,Biopharma Business ,Development Contact ,Health Care Amp Hospitals ,Medical Pharmaceuticals ,Biotechnology ,Computer Amp Electronics ,Artificial Intelligence ,Licensing ,